BSE filing, NSE: NOCIL. Summary written from the filing by ALFA Finder's alert engine.
NOCIL Ltd: key numbers
- Share price
- ₹146.70
- Market cap
- ₹2,450 Cr
- Revenue (annual)
- ₹1,303 Cr
- Net profit (annual)
- ₹55.63 Cr
- P/E (TTM)
- 37.0×Sector 34.1×
- Promoter holding
- 33.76%+0.00% QoQ
- FII holding
- 5.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NOCIL Ltd
All →NOCIL Other Announcement
NOCIL Ltd submitted the Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
NOCIL Board Meeting Date
NOCIL Limited's board will meet on October 29, 2026, to approve un-audited financial results for the quarter ended September 30, 2026. This is a prior intimation of a future board meeting.
NOCIL Price Movement Clarification
NOCIL confirmed no undisclosed price-sensitive information to explain a spurt in trading volume. The company affirmed ongoing compliance with SEBI LODR Regulations.
NOCIL Other Announcement
NOCIL Limited has appointed Deloitte Haskins & Sells Chartered Accountants LLP as its statutory auditor for a five-year term, effective from the upcoming 65th AGM.
NOCIL Earnings Call Transcript: Key Takeaways
NOCIL started FY27 with 20% revenue growth, but temporary utility and logistical constraints hampered volumes. Management remains optimistic, banking on anti-dumping duties and new TDQ plant ramp-ups to offset input cost pressures.
NOCIL Results Update
NOCIL reported Q1FY27 net profit of ₹28 crore and revenue of ₹403 crore. The company also announced an additional ₹130 crore capital expenditure for Dahej capacity.
- Value
- ₹403.0 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date